FR2758263B1 - Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue - Google Patents

Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Info

Publication number
FR2758263B1
FR2758263B1 FR9700412A FR9700412A FR2758263B1 FR 2758263 B1 FR2758263 B1 FR 2758263B1 FR 9700412 A FR9700412 A FR 9700412A FR 9700412 A FR9700412 A FR 9700412A FR 2758263 B1 FR2758263 B1 FR 2758263B1
Authority
FR
France
Prior art keywords
5ht1d
agonist
antagonist
cosmetic
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9700412A
Other languages
English (en)
Other versions
FR2758263A1 (fr
Inventor
Lionel Breton
Isabelle Nonotte
Lacharriere Olivier De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR9700412A priority Critical patent/FR2758263B1/fr
Priority to JP53331398A priority patent/JP2001511782A/ja
Priority to EP98902077A priority patent/EP1014928A2/fr
Priority to PCT/FR1998/000062 priority patent/WO1998031335A2/fr
Publication of FR2758263A1 publication Critical patent/FR2758263A1/fr
Application granted granted Critical
Publication of FR2758263B1 publication Critical patent/FR2758263B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9700412A 1997-01-16 1997-01-16 Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue Expired - Fee Related FR2758263B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9700412A FR2758263B1 (fr) 1997-01-16 1997-01-16 Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
JP53331398A JP2001511782A (ja) 1997-01-16 1998-01-14 敏感肌のための化粧品または皮膚科用組成物における５ｈｔ▲下２▼及び５ｈｔ▲下１ｄ▼レセプターそれぞれに特異的なセロトニンアンタゴニストまたはアゴニストの使用
EP98902077A EP1014928A2 (fr) 1997-01-16 1998-01-14 Utilisation d'un antagoniste et/ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5htid dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
PCT/FR1998/000062 WO1998031335A2 (fr) 1997-01-16 1998-01-14 Utilisation d'un antagoniste et/ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700412A FR2758263B1 (fr) 1997-01-16 1997-01-16 Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Publications (2)

Publication Number Publication Date
FR2758263A1 FR2758263A1 (fr) 1998-07-17
FR2758263B1 true FR2758263B1 (fr) 1999-12-17

Family

ID=9502657

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9700412A Expired - Fee Related FR2758263B1 (fr) 1997-01-16 1997-01-16 Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue

Country Status (4)

Country Link
EP (1) EP1014928A2 (fr)
JP (1) JP2001511782A (fr)
FR (1) FR2758263B1 (fr)
WO (1) WO1998031335A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866567A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation d'un antagoniste du recepteur beta-adrenergique, at1, 5-ht2, 5-ht5 et/ou de la galanine, pour le traitement de la rosacee
WO2005120456A2 (fr) * 2004-06-09 2005-12-22 Pfizer Limited Nouvelle formulation de l'eletriptan
US7744918B2 (en) 2004-11-22 2010-06-29 Hisamitsu Pharmaceutical Co., Inc. Drug-containing patch
FR3015288B1 (fr) 2013-12-19 2016-02-12 Galderma Res & Dev Utilsation du naratriptan dans le traitement de la rosacee
AU2017295038B2 (en) * 2016-07-15 2022-09-22 Centre Hospitalier Sainte Anne Paris 5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair
SE2250051A1 (en) * 2022-01-20 2023-07-21 Amidea Sweden Ab New pharmaceutical composition and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
JPH05502217A (ja) * 1989-08-21 1993-04-22 ベス　イスラエル　ホスピタル　アソシエーション セロトニン拮抗薬の局所用調製物を使用した、皮膚、眼、および粘膜の過敏症、炎症、および過増殖状態の治療のための方法および組成物
ZA906583B (en) * 1989-08-21 1991-09-25 Beth Israel Hospital Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
FR2728258A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un derive de l'ethylene diamine dans une composition cosmetique ou dermatologique et composition contenant notamment un produit a effet secondaire irritant
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
JPH08217695A (ja) * 1995-02-10 1996-08-27 Pola Chem Ind Inc 皮膚外用剤

Also Published As

Publication number Publication date
FR2758263A1 (fr) 1998-07-17
JP2001511782A (ja) 2001-08-14
WO1998031335A2 (fr) 1998-07-23
EP1014928A2 (fr) 2000-07-05
WO1998031335A3 (fr) 1999-09-10

Similar Documents

Publication Publication Date Title
BR9700835A (pt) Composição cosmética contendo um antagonista dos receptores do neuropetídeo y
BR9606619A (pt) Antagonistas do receptor de neuropeptídeo y indolil
LV11460A (lv) Estrogenu agonisti un antagonisti
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
ATE296811T1 (de) Sulfonamid-derivate als 5-ht6 receptor antagonisten und verfahren zu ihrer herstellung
FR2739557B1 (fr) Utilisation d'un ligand agoniste specifique rar-gamma
BR9706385A (pt) Antagonistas de receptores de vitronectina preparação e uso dos mesmos
PT699069E (pt) Antagonistas dos receptores de endotelina
ATE258548T1 (de) Adhäsionsrezeptor-antagonisten
FR2740333B1 (fr) Utilisation d'un antagoniste de substance p dans une composition topique comme agent antitranspirant
FR2737408B1 (fr) Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
NO950606D0 (no) Adhesjonsreseptor-antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
NO975975D0 (no) Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO983871D0 (no) Oksa- og tiadiazol muskarinreseptorantagonister
FR2758263B1 (fr) Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
FR2762907B1 (fr) Dispositif pour mesurer la rotation d'un element tournant
ITMI922854A1 (it) Uso degli antagonisti dei recettori 5-ht3
FI953720A (fi) Neurotensiiniantagonistien käyttö diureettietan lääkkeiden valmistamiseksi
NO964670D0 (no) Nye opioidpeptidanaloger med blandete my agonist/ antagonist-egenskaper
ZA9610116B (en) Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use
DK0786002T3 (da) Intracellulær isoform af interleukin-1-receptorantagonisten
DE59503324D1 (de) Adhäsionsrezeptor-Antagonisten

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100930